Same spot every week feels convenient. It's also the single most common cause of a slower, less predictable response to a GLP-1 shot. Here's the tissue mechanism, and the rotation pattern that avoids it.
Every subcutaneous injection is a small, repeated trauma to the same layer of tissue. Do it in the same square centimeter of skin week after week and the tissue responds by thickening — fat cells enlarge and fibrous scar tissue builds up under the skin. This is lipohypertrophy: a firm, sometimes numb lump that forms at an overused injection site.
It's the best-documented complication of long-term self-injection, originally described in people using daily insulin, where the injection frequency is much higher than a weekly GLP-1 shot — but the mechanism is identical, and the risk grows the longer any injectable therapy continues.
Thickened, fibrotic tissue doesn't absorb medication the way healthy subcutaneous fat does. Injecting into a lipohypertrophic site slows and flattens absorption — the drug enters circulation more slowly and less predictably than the trial data (and your prescribed dose) assumes.
For insulin, this is well established to cause erratic blood sugar control. For weekly GLP-1 therapy, the same absorption variability can show up as an inconsistent response week to week — days where the effect feels stronger or weaker for no obvious reason, even at an unchanged dose.
The pattern with the most supporting evidence rotates through six zones — left and right abdomen, left and right thigh, left and right upper arm — moving to a new zone each week and keeping injection points at least 2.5–5 cm apart within the same zone.
Basis: Injection-site rotation guidance derived from insulin self-injection literature and manufacturer instructions for use for semaglutide and tirzepatide pens. See site rotation overview.
The exact order doesn't matter as much as never repeating a zone two weeks running, and checking each site before injecting — any lump, firmness, or numbness means that spot needs longer to recover, regardless of where the cycle says to go next.
GLP1ShotDay logs the site with every shot and highlights the next zone in the rotation, so you're not trying to remember which arm you used three Thursdays ago.
This article summarizes general injection-site rotation guidance. It is not medical advice. If you notice persistent lumps, unusual pain, or signs of infection at an injection site, contact your prescriber.